Our mission is to advance phage therapy discussion, study, and use in Canada.
Our vision is to reduce the impact of antibiotic resistant infections with an innovative and appropriately regulated biologic therapeutic.
Our working group is organized into four streams:
Clinical and Research – Regulatory – Laboratory – Engagement
Should you have any questions or suggestions, or wish to apply to be a member of the Phage Therapy Working Group, please contact Dr. Marek Smieja, Working Group Chair, at smiejam@mcmaster.ca
The G-CPR is composed of a collaborative group of international infectious diseases physicians, microbiologists, and phage scientists. These rounds enable confidential discussion on de-identified cases undergoing consideration for phage therapy. AMMI Canada was a founding sponsor of G-CPR and continues to provide logistical support, branding, and communications.
